COVID-19 Updates
From the Journals
Immune response may explain brain damage after COVID-19
Antibodies appear involved in an attack on the cells lining the brain’s blood vessels.
Latest News
Biden tests positive for COVID-19: White House
President Biden plans to isolate at the White House and “will continue to carry out all of his duties fully during that time.”
News
Shift schedule today could worsen that stroke tomorrow
Plus: Feed your soul with online art, feed your “hangry” etymologist, but don’t feed anyone with SARS-CoV-2 from the freezer.
Conference Coverage
In utero COVID exposure tied to developmental differences in infants
“We don’t know if these effects will result in any longer-term issues,” but longer-term observation “may help us understand this.”
FDA/CDC
FDA panel strongly backs protein-based Novavax COVID-19 vaccine
“Having a protein-based alternative may be more comfortable for some in terms of their acceptance of vaccines.”
Latest News
How to manage drug interactions with Paxlovid for COVID-19
“There is a concern that people have not been prescribing it because of fear of these interactions.” In some cases those fears may be valid, in...
Conference Coverage
Anxiety in America: COVID ‘takes a backseat’ to global events
Nearly three-quarters (73%) of U.S. adults are somewhat or extremely anxious about current events happening around the world.
Conference Coverage
COVID-19 burnout? Turn off your mind, relax, and float downstream
Latest News
Omicron breakthrough cases boost protection, studies say
“We should think about breakthrough infections as essentially equivalent to another dose of vaccine.”
From the Journals
Neuropsychiatric risks of COVID-19: New data
“Neuropsychological sequelae need to be considered after all severe respiratory infections, rather than only following severe COVID-19,” said Dr....
From the Journals
Most COVID-19 survivors return to work within 2 years
Survivors report more symptoms than controls, but overall symptom burden decreased over time.